POMDOCTOR Ltd
POMDOCTOR Ltd
Your view on POM
Overview
What the company does, where it operates, and who runs it.
About POMDOCTOR Ltd
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Zhenyang Shi
- Headquarters
- CN
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Zhenyang Shi
- Headquarters
- CN
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China.
The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.
The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for POMDOCTOR Ltd, and the rating behind it. POM last traded at $0.73; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for POMDOCTOR Ltd. Starting points for POMDOCTOR Ltd: EPS -$3.66, beta 2.28 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for POMDOCTOR Ltd. POMDOCTOR Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for POMDOCTOR Ltd. Trailing twelve-month EPS for POMDOCTOR Ltd stands at -$3.66. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for POMDOCTOR Ltd. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
POMDOCTOR Ltd valued side by side against its closest peers. POMDOCTOR Ltd is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold POMDOCTOR Ltd, and how their positions are changing. At a $4.9M market value, institutional positions materially move POMDOCTOR Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by POMDOCTOR Ltd executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming POMDOCTOR Ltd. POMDOCTOR Ltd is a $4.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming POMDOCTOR Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for POMDOCTOR Ltd. Coverage tracks POMDOCTOR Ltd within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.